Guidelines for the production, control and regulation of snake antivenom immunoglobulins;Recommandations pour la production, le contrôle et l'enregistrement des immunoglobulines antivenimeuses

Biologie Aujourd'hui

Volumn 204, Issue 1, 2010, Pages 87-91

  Chippaux, Jean Philippe ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

antivenom; envenomations; Immunotherapy; snakes; world health organization

Indexed keywords

IMMUNOGLOBULIN; VENOM ANTISERUM;

AFRICA SOUTH OF THE SAHARA; ANIMAL; ARTICLE; HUMAN; IMMUNOLOGY; MORTALITY; SNAKE; SNAKEBITE; WORLD HEALTH ORGANIZATION;

AFRICA SOUTH OF THE SAHARA; ANIMALS; ANTIVENINS; HUMANS; IMMUNOGLOBULINS; SNAKE BITES; SNAKES; WORLD HEALTH ORGANIZATION;

SERPENTES;

EID: 78149273779     PISSN: 21050678     EISSN: 21050686     Source Type: Journal    
DOI: 10.1051/jbio/2009043     Document Type: Article

References (13)

1. Burnouf T., Griffiths E., Padilla A., Seddik S., Stephano M.A., Gutiérrez J.M., Assessment of the viral safety of antivenoms fractionated from equine plasma. Biologicals, 2004, 32, 115-128.
2. Burnouf T., Radosevich M., Goubran H.A., Willkommen H., Place of nanofiltration for assuring viral safety of biologicals. Curr Nanosci, 2005, 1, 189-201.
3. Chippaux J.-P., The development and use of immunotherapy in Africa. Toxicon, 1998, 36, 1503-1506.
4. Chippaux J.-P., Estimating the global burden of snakebite can help to improve management. PLoS Medicine, 2008, 5, e221.
5. Chippaux J.-P., Immunothérapie d'urgence: antivenins de serpents et de scorpions. Biologie Aujourd'hui, 2010, 204, 61-70.
6. Chippaux J.-P., Stock R., Massougbodji A., Review: Methodology of clinical studies dealing with the treatment of envenomation. Toxicon, 2010, soumis.
7. Gutiérrez J.M., Higashi H.G., Wen F.H., Burnouf T., Strengthening antivenom production in Central and South American public laboratories: Report of a workshop. Toxicon, 2006, 49, 30-35.
8. Ramos-Cerrillo B., de Roodt A., Chippaux J.-P., Olguín L., Casasola A., Guzmán G., Paniagua-Solís J., Alagón A., Stock R.P., Characterization of a new polyvalent antivenom (Antivipmyn Africa $^{\circledR}$) against African vipers and elapids. Toxicon, 2008, 52, 881-888.
9. Stock R.P, Massougbodji A., Alagón A., Chippaux J.-P., Bringing antivenom to Sub-Saharan Africa. Nature Biotechnol, 2007, 25, 173-177.
10. Theakston R.D., Warrell D.A., Crisis in snake antivenom supply for Africa. Lancet, 2000, 356, 2104.
11. Theakston R.D., Warrell D.A., Griffiths E., Report of a WHO workshop on the standardization and control of antivenoms. Toxicon, 2003, 41, 541-557.
12. WHO. Guidelines on Production, Control and Regulation of snake antivenom immunoglobulins, OMS, Genève, sous presse.
13. WHO. Rabies and envenomings. A neglected public health issue. Report of a consultative meeting, OMS, Genève, 2007, p. 32 http://www.who.int/ bloodproducts/animal-sera/Rabies.pdf